---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-025782"
form_type: "8-K"
ticker: "RMTI"
cik: "0001041024"
company_name: "ROCKWELL MEDICAL, INC."
filed_at: "2025-03-20T23:59:59+00:00"
generated_at: "2026-05-24T09:40:29.854905+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Rockwell Medical Reports Record Net Sales and First Full-Year Adjusted EBITDA Profitability in 2024

## Summary
- Record net sales of $101.5M in 2024, a 21% increase over 2023.
- Record gross profit of $17.5M in 2024, a 101% increase over 2023.
- Full-year adjusted EBITDA reached $5.2M, first time profitable on that basis.
- Net loss improved 94% to $0.5M in 2024 from $8.4M in 2023.
- Largest customer transitioning away; expects ~$34M revenue loss in 2025.

## SEC filing metadata
- accession: 0001104659-25-025782
- form_type: 8-K
- ticker: RMTI
- cik: 0001041024
- company_name: ROCKWELL MEDICAL, INC.
- filed_at: 2025-03-20T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1041024/000110465925025782/0001104659-25-025782-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1041024/000110465925025782/tm259810d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-025782
- JSON: https://secwatch.observer/filing/0001104659-25-025782.json
- Plain text: https://secwatch.observer/filing/0001104659-25-025782.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.